Generalized Anxiety Disorder Clinical Trial
Official title:
The Effects of Yoga and Quiet Rest on Subjective Levels of Anxiety and Physiological Correlates: A 2-way Randomized Crossover Design
A randomized repeated-measures crossover clinical trial was performed. Forty healthy, female college students completed a 30 min session of YogaFit and a time-matched seated rest condition on separate days. After each condition, participants viewed 30 min of emotional picture stimuli. State anxiety, heart rate and time-domain and frequency-domain measures of HRV were assessed baseline, post- condition, and post-exposure to emotional stimuli. Data were analysed using a condition x time (2 × 3) repeated-measures ANOVA.
The design was a repeated-measures randomized crossover trial. Each study participant
completed 4 different sessions on 4 different days: (day 1) participant screening; (day 2 or
3) study condition A (seated, quiet rest); (alternate day 2 or 3) study condition B
(moderate-intensity YogaFit); and (day 4) a session to rate IAPS pictures (14) and undergo a
single DEXA scan [Prodigy/301776R. G.E. Medical Systems-Lunar DEXA Scanner, Fairfield, CT,
USA]. Utilizing a simple randomization process, participants were randomized in a 1:1 ratio
to participate in either the YogaFit condition or the quiet rest condition. The study
conditions were counterbalanced and alternated using odd and even numbers to begin the
sequence. Participants were not informed if the first condition was A or B. Self-reported
anxiety levels and 10 min of continuous physiological data were collected: (a) baseline; (b)
post-condition; and (c) post-exposure for both condition A and B. All participants completed
both the psychological and physiological assessments. Both experimental conditions A and B
were completed in 90 min. To ensure compliance, participants were observed through a glass
window every 10 min during study conditions. Testing time and procedures were identical with
the exception of the experimental condition on days two and three.
All participants were familiarized with the videotaped YogaFit session before participating
in the study. Participants were instructed to arrive for all visits dressed in loose fitting
athletic wear and were asked to refrain from all food, alcohol, caffeine, gum chewing or the
use of tobacco products 3 h before their scheduled meeting in the laboratory.
During pre-screening, participants completed: (a) a standard health history questionnaire;
(b) the STAI-Y2; (c) the BDI and (d) a custom DEXA safety questionnaire. Qualified
participants were then asked to track their menstrual cycle using a menstrual log and e-mail
the primary investigator on day 1 of the follicular phase of their menstrual cycle, thus
using the first day of the women's menstrual cycle to generate an unpredictable random
sequence and to eliminate any sequence bias. The participant was then scheduled for condition
A first or condition B first. The conditions were counterbalanced to control for order
effects, with odd numbers beginning condition A first and even numbers beginning condition B
first. To control for the effects of the menstrual cycle on anxiety, participants completed
condition A and condition B within a 7-day period during the follicular phase of their
menstrual cycle (specifically days 1-10). Participants were also asked to maintain pre-study
physical activity levels during the 7-day period. All testing was completed by day 10 of
their menstrual cycle. State anxiety was psychologically quantified using a reliable and
validated assessment of anxiety, Spielberger's State-Trait Anxiety Inventory (STAI-YI).
Instruments for testing all physiological variables were calibrated and used by the same
investigator in order to control possible inter-tester variation. During both condition A and
B, a ProComp Infiniti System with Biograph software version 6.0 was used to measure HR and
indices of HRV at a sampling rate of 2048 cycles per sec at the 3 different time points.
Three electrodes were placed on the participants to monitor HR as specified by the ProComp
Infiniti System. The negative electrode was placed in the right shoulder fossa below the
clavicle, the positive electrode was placed medially on the thorax below the sternum, and the
ground electrode was placed in the left shoulder fossa below the clavicle. Indices of HRV
included the time-domain variable, root mean square of successive differences (RMSSD) and two
frequency-domains: the low frequency power bands and the high frequency power bands in
normalized units (LFNU and HFNU, respectively).
Measures of HR and HRV were analysed using CardioPro Infinity-HRV Analysis Software
Module-SA7J90 [ProComp Infiniti System, Montreal, Quebec, Canada: Cimetra LLC]. An
accelerometer using the ActiLife 6 Software and a Polar Heart Rate Sensor were strapped to
the participant and used to monitor the intensity level of both study conditions A and B. The
accelerometer was used only to record HR data and no other accelerometer data were analysed.
Participants were then informed of the experimental condition. For study condition A (quiet,
seated rest), participants sat on a yoga mat in a cross-legged position for 30 min in a quiet
laboratory setting. For study condition B [YogaFit Vinyasa Flow (referred to as YogaFit in
this manuscript)], participants followed, via digital versatile disc, a standardized YogaFit
format choreographed by a certified American Council of Exercise Instructor and Registered
Yoga Alliance Teacher. Yoga- Fit was performed in the same laboratory setting and lasted 30
min. There are 7 principles of alignment that are applied in every YogaFit session: (1)
establish a base and dynamic tension; (2) create core stability; (3) align the spine; (4)
soften and align the knees; (5) relax shoulders back and down; (6) hinge at the hips; and (7)
shorten the lever. The YogaFit essence is based on: Breathing, Feeling, Listening to the
Body, Letting Go of Competition, Judgement, Expectations, and Staying in the Present Moment.
The movements included in each specific phase were chosen from Beth Shaw's YogaFit Vinyasa
Flow Series. To measure intensity of theYogaFit routine, ratings of perceived exertion (RPE)
[24] were recorded following both condition A and B. The accelerometer and heart rate sensor
were removed after the study condition. After both study conditions, participants again
completed STAI-Y1 and 10 min of post-condition data were collected. Participants then viewed
90 emotionally arousing pictures from the IAPS after both study conditions A and B. Pictures
were viewed on a 70" × 70"portable projection screen. The 90 pictures were arranged in 3
blocks of 30; each block contained 10 pictures from each valence category. Among the 90
pictures used, 30 were pleasant (15 erotica and 15 babies, families, and cute animals); 30
were neutral (15 neutral people and 15 neutral objects and scenes); and 30 were unpleasant
(15 threat and 15 mutilation) based on normative ratings of valence [5]. No more than two
pictures from the same category appeared consecutively. Two different picture orders were
constructed and counterbalanced across testing day and experimental condition. Each picture
was shown for 4-s, followed by a 12-, 14-, or 16-s inter-picture interval, which consisted of
a centrally located fixation cross. The total picture-viewing time, including brief breaks
between each picture block, was approximately 30 min. Participants were instructed to look at
each picture the entire time it was on the monitor and to subjectively categorize each
picture as pleasant, neutral, or unpleasant using a response pad [E-Prime 2.0, Psychology
Software Tools, Inc., Pittsburgh, PA, USA] resting on their lap. These ratings were not used
to compare to the normative ratings, but rather, the purpose of categorizing the pictures was
to ensure that participants concentrated on the pictures. Immediately after viewing the
pictures, participants again completed STAI-Y1 and 10 min post-exposure data were collected.
In accordance with the Center for the Study of Emotion and Attention, participants were also
asked to rate the IAPS images in order to further image standardization. Participants rated
each of the 90 pictures (hard copy, one picture per page in a standard, self-paced order)
using the Self-Assessment Manikin (SAM) during visit 4 to the laboratory. Additionally,
participants underwent a single DEXA scan for body composition assessment.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03420456 -
Transcranial Pulse Near-Infrared Light in Generalized Anxiety Disorder: a Placebo-Controlled Study
|
N/A | |
Active, not recruiting |
NCT05530642 -
An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel
|
N/A | |
Withdrawn |
NCT02382224 -
Worry Exposure for Generalized Anxiety Disorder
|
N/A | |
Completed |
NCT02256566 -
Cognitive Training for Mood and Anxiety Disorders
|
N/A | |
Completed |
NCT02306356 -
Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical Setting
|
N/A | |
Completed |
NCT01958788 -
Testing Beliefs About Uncertainty in the Treatment of Generalized Anxiety Disorder
|
N/A | |
Completed |
NCT01681329 -
Cognitive-Behavioral Treatment and Interpretation Modification Training for Adults With Generalized Anxiety Disorder
|
N/A | |
Completed |
NCT01342120 -
PHARMO Institute Seroquel Safety Study
|
N/A | |
Completed |
NCT01337713 -
Efficacy of Massage Therapy in the Treatment of Generalized Anxiety Disorder (GAD)
|
N/A | |
Completed |
NCT01201967 -
A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients
|
Phase 4 | |
Completed |
NCT01971203 -
Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat
|
N/A | |
Completed |
NCT01203293 -
Cognitive Behavioral Therapy (CBT) for Latinos With Generalized Anxiety Disorder in the General Medical Sector
|
Phase 1 | |
Completed |
NCT00961298 -
An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder
|
Phase 4 | |
Completed |
NCT00711737 -
Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months
|
N/A | |
Terminated |
NCT01244711 -
Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines
|
Phase 4 | |
Completed |
NCT00744627 -
Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults.
|
Phase 3 | |
Completed |
NCT00515242 -
Therapeutic Massage for Generalized Anxiety Disorder
|
Phase 1/Phase 2 | |
Completed |
NCT00537615 -
An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers
|
Phase 1 | |
Completed |
NCT00525226 -
Evaluating the Effects of Stress in Pregnancy
|
N/A | |
Completed |
NCT00368745 -
Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use.
|
Phase 3 |